Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort study
Thrombocytopenia in APS patients, particularly in severe cases, correlates with heightened thrombotic risk and systemic manifestations. These findings highlight the importance of customized strategies that balance thrombosis prevention with bleeding risk, especially in complex cases.
Authors
- Sofia Camerlo (ORCID: https://orcid.org/0000-0002-0388-955X)
- Irene Cecchi (ORCID: https://orcid.org/0000-0002-1858-5452)
- Savino Sciascia (ORCID: https://orcid.org/0000-0003-1266-9441)
- Alessandro Morotti (ORCID: https://orcid.org/0000-0002-8407-2903)
- David Galarza
- Massimo Radin (ORCID: https://orcid.org/0000-0003-1941-2606)
- Alice Barinotti (ORCID: https://orcid.org/0000-0002-7354-7002)
- Roberta Fenoglio (ORCID: https://orcid.org/0000-0001-8019-5749)
- Isabella Russo (ORCID: https://orcid.org/0000-0002-2921-1763)
Institutions
- CTO Andrea Alesini (IT)
- Hospital Del Mar (ES)
- University of Turin (IT)
Publication Details
- Journal
- Thrombosis Research
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.thromres.2025.109544
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00